CClinicalTrials.gg
CompletedNCT05296343S-Urg-QualiUpdated Nov 12, 2024

Guidelines for Parental Involvement in the Care of Suicidal Youth

An observational study in Suicide, Attempted and Emergencies, sponsored by University Hospital, Clermont-Ferrand. Completed at 1 site in France. Open to participants aged 15 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-11-12.

Sponsored by University Hospital, Clermont-Ferrand · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
61
Ages
15 Years to 25 Years
Sex
All
01

Study summary

Parents occupy a central place in the emergency care of suicidal adolescents and young adults. However, from 15 to 25yo, three different administrative situations exist in France:

  • \<16yo: admission to a child ED by a team trained to receive the youngest patients.
  • 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
  • >18yo: admission to an adult ED by team.

Laying on qualitative observational protocol and a Delphi approach, this study will explore the perspective of adolescents and young adults following a suicidal attempt, the perspective of their parents, and the perspective of their healthcare professionals to build guidelines for parental involvement in care of suicidal youths.

Read the detailed description

Suicide is the second leading cause of death among 15-25 year olds, with the highest rate of hospitalization for SC of any age group. The psychopathology of suicidal behavior in adolescents and young adults (AYA) is homogeneous: risk factors, precipitating factors, representations. Parents occupy a central place in care. They are i) involved in the care decision; ii) actively involved in care; and ii) a source of motivation for trust and adherence to care.

However, if the psychopathology of suicidal crisis is homogeneous, the transition between pediatric and adult care implies very different management in the emergency department (ED). In France, three situations can be described:

  • \<16yo: admission to a child ED by a team trained to receive the youngest patients.
  • 16-18yo: admission to an adult ED by team devoted to adult care, no exit without parents' authorization.
  • >18yo: admission to an adult ED by team devoted to adult care, no right to contact the parents in case of patient opposition.
  • Before 16 years of age: admission to the children's UAS, care by a team trained to receive the youngest patients.
  • 16-18 years: admission to the adult UAS, care by adult professionals, clinical and legal particularities of care for minors.
  • After 18 years old: admission to adult UAS, legal constraints of the adult care setting.

The objectives of this qualitative observational study is to build guidelines for the involvement of the parents in the care in these three situations.

The study will include adolescents and young adults from the three situations, their parents and the professionals who take care of them. Individual semi-structured interviews will be organized to collect their experiences. Qualitative analyses will be conduct, following Interpretative Phenomenological Analysis. A pre-approved guideline will be construct and a Delphi approach will be conducted to approved the final version of the guideline.

02

Conditions studied

  • Suicide, Attempted
  • Emergencies

Keywords

  • Adolescent
  • Parent
  • Qualitative study
  • Guidelines
03

In context

Emergencies

1,692 studies on the registry are indexed under Emergencies; 333 are open to participants now.

This study's enrollment of 61 is below the median of 353 across 714 observational studies indexed under Emergencies.

Browse Emergencies studies →

Lead sponsor

University Hospital, Clermont-Ferrand is the lead sponsor of 841 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
15 Years to 25 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Any adolescent and young adult admitted to an Emergency Department (ED) in one of the inclusion center following a suicidal act or considered as such by the medical team. Their parents; healthcare professionals working in ED of the inclusion centers.

Inclusion criteria

Adolescents and Young adults

  • Admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team

Parents

  • Parents of the included youths >18y

Healthcare professionals

  • >18y
  • Working in ED
  • Usually taking care of suicidal youths

All the participants

  • French speaking
  • Affiliation to a social security regime
  • Participation agreement

Exclusion criteria

Exclusion Criteria:

All the participants

  • Present an acute somatic or psychiatric disease which may hinder the well organization of the interview
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
61 participants (actual)
Patient registry
No

Groups and cohorts

  • Adolescents and young adults

    Boys and girls from 15 to 25 years old admitted to an Emergency Department (ED) following a suicidal act or considered as such by the medical team

  • Parents

    One or the two parents of the included adolescents and young adults

  • Healthcare professionals

    Professionals working in one emergency departments of the inclusion centers and who usually take care of suicidal adolescents and young adults

06

What researchers measure

Primary outcomes

  1. Developing guidelines defining the role of parents in the medical decision and the care of the youths

    Thematic framework summarizing the perspectives of three groups of participants.

    Time frame: Day 1

Secondary outcomes

  1. Describing each context of care

    Qualitative description of each of the three context of care (\<16y, 16-18y, \>18y)

    Time frame: Day 1

  2. Describing expectations from each group

    Qualitative description of each of the three participant groups (adolescents and young adults, parents, professionals)

    Time frame: Day 1

07

Study locations

1 site
  • CHU de Clermont-Ferrand
    Clermont-Ferrand, 63000, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05296343
Lead sponsor
University Hospital, Clermont-Ferrand
Responsible party
Sponsor
First posted
Mar 25, 2022
Start date
May 18, 2022
Primary completion
Oct 31, 2024
Completion
Oct 31, 2024
Last update
Nov 12, 2024

Study contacts

Jonathan Lachal
principal investigator · University Hospital, Clermont-Ferrand

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion